Home > Entelos Salary

Entelos Salary

  • 71
  • 73
  • 87
Entelos average salary is $38,000, median salary is $38,000 with a salary range from $38,000 to $38,000.
Entelos salaries are collected from government agencies and companies. Each salary is associated with a real job position. Entelos salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
38,000
Average
38,000
Median
38,000
High
38,000
Total 1 Entelos Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Entelos salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Entelos Jobs
See more Entelos Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Patents information
260

All Patents

27

Grant Patents

204

Patents Pending

45

Patents Families

More Recent
Entelos... Information
  • Entelos Inc
  • Industry: Biotech/Healthcare
  • City: Foster City, CA
  • Entelos, Inc. (http://www.entelos.com), headquartered in Menlo Park, California, is the leader in predictive biosimulation for in silico drug discovery & development. The company's patented PhysioLab(TM) technology provides a breakthrough platform for testing experiments & hypotheses in silico, predicting the results through simulation, & creating knowledge out of fragmented discovery and clinical data. Entelos provides integrated expertise in the metabolic, immunologic, & respiratory areas, & currently offers PhysioLab systems for asthma, obesity, diabetes, and adipocytes. Access to Entelos technology and expertise is available through R&D collaborations, research agreements, and licensing. The company plans to expand its in silico R&D capabilities based